Concepedia

Author

D. Church

Bayer (United States)

Also Known As

D A Church, D CHURCH, D Church, D. CHURCH, D. Church, D.A. Church, DANIEL CHURCH

18

Publications

486

Citations

7

H-Index

17

Concepts

All Affiliations

Bayer (United States)
DC

About

D. Church is an author at Bayer (United States) specializing in medicine, clinical microbiology, and infection control.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

462

2

Pulmonary Medicine

3

3

285

3

Health Sciences

2

2

151

4

Microbiology

1

1

98

5

Pharmacology

1

1

53

D. Church

×

6

Publications

462

Citations

6

H-Index

YearCitations

Short-course moxifloxacin therapy for treatment of acute bacterial exacerbations of chronic bronchitis

Sanford Chodosh, C. Andrew DeAbate, Daniel Haverstock,

Respiratory Medicine

2000

136

Comparison of two beta-lactamase-producing strains of Streptococcus faecalis

B E Murray, D. Church, Audrey Wanger,

Antimicrobial Agents and Chemotherapy

1986

98

The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis

C. Andrew DeAbate, Chavaramplakic P. Mathew, John Harley Warner,

Respiratory Medicine

2000

96

MOXIFLOXACIN VERSUS CEPHALEXIN IN THE TREATMENT OF UNCOMPLICATED SKIN INFECTIONS

LC Parish, HB Routh, Barry Miskin,

International Journal of Clinical Practice

2000

53

Efficacy and safety of ten day moxifloxacin 400 mg once daily in the treatment of patients with community-acquired pneumonia

Twisha S Patel, Jeffrey Pearl, Julian Williams,

Respiratory Medicine

2000

53

Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia

H. Lode, Charles M. Grossman, Shurjeel Choudhri,

Respiratory Medicine

2003

26

Page 1